Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Branković, Marija

  • Google
  • 3
  • 26
  • 1

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (3/3 displayed)

  • 2022Clinical exome sequencing in Serbian patients with movement disorders: Single centre experience1citations
  • 2022Analysis of “clinical exome” panel in Serbian patients with cognitive disorderscitations
  • 2018HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.citations

Places of action

Chart of shared publication
Kostic, Vladimir
2 / 2 shared
Bergant, Gaber
2 / 2 shared
Jankovic, Milena
2 / 2 shared
Peterlin, Borut
2 / 2 shared
Novakovic, Ivana
2 / 2 shared
Peric, Stojan
1 / 1 shared
Maver, Ales
2 / 2 shared
Petrovic, Igor
1 / 1 shared
Dragasevic, Natasa
1 / 1 shared
Dobricic, Valerija
2 / 3 shared
Marjanovic, Ana
2 / 2 shared
Svetel, Marina
1 / 1 shared
Jancic, Jasna
1 / 3 shared
Stefanova, Elka
1 / 1 shared
Stevic, Zorica
1 / 1 shared
Mandic, Gorana
1 / 1 shared
Dzamic, Zoran
1 / 3 shared
Nikolic, N.
1 / 4 shared
Basta Jovanovic, G.
1 / 2 shared
Carkic, J.
1 / 2 shared
Marjanovic, A.
1 / 2 shared
Radojevic Skodric, S.
1 / 2 shared
Prvanovic, Mirjana
1 / 1 shared
Jovanovic, A.
1 / 3 shared
Milasin, J.
1 / 2 shared
Trifunović, Jovanka
1 / 2 shared
Chart of publication period
2022
2018

Co-Authors (by relevance)

  • Kostic, Vladimir
  • Bergant, Gaber
  • Jankovic, Milena
  • Peterlin, Borut
  • Novakovic, Ivana
  • Peric, Stojan
  • Maver, Ales
  • Petrovic, Igor
  • Dragasevic, Natasa
  • Dobricic, Valerija
  • Marjanovic, Ana
  • Svetel, Marina
  • Jancic, Jasna
  • Stefanova, Elka
  • Stevic, Zorica
  • Mandic, Gorana
  • Dzamic, Zoran
  • Nikolic, N.
  • Basta Jovanovic, G.
  • Carkic, J.
  • Marjanovic, A.
  • Radojevic Skodric, S.
  • Prvanovic, Mirjana
  • Jovanovic, A.
  • Milasin, J.
  • Trifunović, Jovanka
OrganizationsLocationPeople

article

Analysis of “clinical exome” panel in Serbian patients with cognitive disorders

  • Kostic, Vladimir
  • Stefanova, Elka
  • Dobricic, Valerija
  • Stevic, Zorica
  • Bergant, Gaber
  • Jankovic, Milena
  • Peterlin, Borut
  • Branković, Marija
  • Novakovic, Ivana
  • Marjanovic, Ana
  • Mandic, Gorana
  • Maver, Ales
Abstract

<jats:p>As life span rises, dementia has become a growing public health issue.According to current estimates, almost 50 million people worldwide havedementia, and the number is expected to grow. Next generation sequencing(NGS) methods have helped significantly with identifying causative genevariants related to various cognitive disorders. Our study aimed to analyzethe genetic basis of cognitive disorders using NGS clinical exome panel. Thestudy included a total number of 15 unrelated cases diagnosed with cognitivedisorders, all negative after standard targeted genetic testing wasperformed (available at Neurology Clinic, UCCS, Belgrade, Serbia).Preference was given to familial cases with early presentation or complexphenotype. Sequencing of a clinical exome (CE) panel for 4813 genes withknown associated clinical phenotypes was performed using TruSight Onesequencing panel on an Illumina MiSeq NGS platform according to themanufacturer?s instructions (Illumina, San Diego, CA, USA). Variants wereanalyzed with Illumina Variant Studio v3 software provided by Illumina aswell as a previously developed pipeline. Variants analysis andinterpretation were based on phenotype gene target approach, literature anddatabases search, allele frequency, and pathogenicity prediction by insilico software. All causative variants were confirmed by Sanger sequencing.Whenever possible, additional family members were studied for segregationanalysis. CE panel analysis revealed a likely genetic cause in fourpatients. We have detected two missense heterozygous pathogenic variants inthe PSEN1 gene in one patient each and homozygous nonsense pathogenicvariant in the OPTN gene in two more patients. Detected pathogenic variantsare in line with the clinical phenotype of our patients. In the rest of the11 cases, genetic diagnosis remains unclear. The results of our studyemphasize the significance of CE panel analysis in establishing a diagnosisfor patients with dementia. Furthermore, give us insight into the complexityof the genetic background of this group of disorders.</jats:p>

Topics
  • impedance spectroscopy